Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United — Fundamental Analysis, Key Performance Indications
/
Date16 Nov 2018
Email Print Friendly Share NEW YORK, Nov. 16, 2018 (GLOBE NEWSWIRE) — In new independent research reports released early this morning, Fundamental Markets released its... Read More →
QPAGOS Reports Another Strong Revenue Growth Quarter
/
Date16 Nov 2018
Email Print Friendly Share MEXICO CITY, Nov. 16, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – QPAGOS (QPAG: OTCQB), an electronic payments solutions provider, announced strong 3rd... Read More →
First Midwest Bancorp, Inc. Announces a 9% Dividend Increase
/
Date16 Nov 2018
Email Print Friendly Share CHICAGO, Nov. 16, 2018 (GLOBE NEWSWIRE) — First Midwest Bancorp, Inc. (“First Midwest”) (NASDAQ NGS: FMBI), the parent company of First... Read More →
Connect for Health Colorado® Reports Increase in 2019 Medical Plan Selections
/
Date16 Nov 2018
Email Print Friendly Share Denver, CO, Nov. 16, 2018 (GLOBE NEWSWIRE) — DENVER — More than 25,000 Coloradans selected health coverage through Connect for Health... Read More →
Majedie Asset Management Ltd: Form 8.3 – BARRICK GOLD CORP
/
Date16 Nov 2018
Email Print Friendly Share FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of... Read More →
ICE District Celebrates Topping Off of the Tallest Tower Outside of Toronto
/
Date16 Nov 2018
Email Print Friendly Share ICE District officially tops off Stantec Tower from the highest vantage point in the city EDMONTON, Alberta, Nov. 16, 2018 (GLOBE... Read More →
Fragrance Creators Association Celebrates Impact, Signals Future at 2018 Annual Meeting
/
Date16 Nov 2018
Email Print Friendly Share Robert Weinstein, PhD, President & CEO, Robertet USA, and Fragrance Creators Association Board Chairman; John Carey Senior Manager, Global Regulatory Services,... Read More →
Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology
/
Date16 Nov 2018
Email Print Friendly Share Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids to treat adult patients with recurrent glioblastoma... Read More →
AMCI Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering
/
Date16 Nov 2018
Email Print Friendly Share New York, NY, Nov. 15, 2018 (GLOBE NEWSWIRE) — AMCI Acquisition Corp. (the “Company”) announced today that it priced its initial... Read More →